StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > News Release!

<< Previous

Bullboard Posts

Next >>

Comment by Kabronon Nov 20, 2020 8:01am

147 Views

Post# 31939257

RE:News Release!

The following has been achieved in the six weeks post the third quarter: Signed multiple new partners, including the Government of Barbados. Introduced a respiratory panel test (testing for 18 virus and 2 bacteria). Expanding testing options with nasal swabs and antigen tests. Expanded testing in Canada via the Company's partnership with Ichor Blood Services. Hired further staff and expanded testing capacity, both for COVID-19 and Aristotle.

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features